Skip to main content
. 2021 May 17;11:10387. doi: 10.1038/s41598-021-89991-x

Table 5.

Survey weighted odds ratios (95% CI) for association between serum iron and presence of NAFLD or AHF.

Quartile for serum iron P-trend
Quartile 1 Quartile 2 Quartile 3 Quartile 4
NAFLD
Males
Cases/N 2577/4815 2295/4545 2062/4264 1874/4407
Model 1 1.00 (Ref.) 0.86 (0.77–0.97) 0.78 (0.70–0.88) 0.67 (0.60–0.75)  < 0.001
Model 2 1.00 (Ref.) 0.89 (0.79–0.99) 0.80 (0.71–0.90) 0.69 (0.62–0.78)  < 0.001
Model 3 1.00 (Ref.) 0.89 (0.79–1.00) 0.81 (0.72–0.91) 0.70 (0.63–0.79)  < 0.001
Females
Cases/N 2471/5122 2128/4887 1735/4711 1130/4269
Model 1 1.00 (Ref.) 0.77 (0.69–0.86) 0.55 (0.50–0.62) 0.36 (0.32–0.41)  < 0.001
Model 2 1.00 (Ref.) 0.78 (0.69–0.87) 0.58 (0.51–0.65) 0.39 (0.34–0.45)  < 0.001
Model 3 1.00 (Ref.) 0.78 (0.69–0.87) 0.58 (0.51–0.65) 0.39 (0.34–0.45)  < 0.001
AHF
Males
Cases/N 237/4796 179/4522 131/4235 99/4382
Model 1 1.00 (Ref.) 0.88 (0.64–1.20) 0.76 (0.55–1.06) 0.63 (0.44–0.90) 0.006
Model 2 1.00 (Ref.) 0.92 (0.67–1.26) 0.80 (0.57–1.12) 0.70 (0.49–1.01) 0.031
Model 3 1.00 (Ref.) 0.92 (0.66–1.26) 0.79 (0.56–1.12) 0.72 (0.50–1.04) 0.046
Females
Cases/N 202/5102 198/4869 157/4690 83/4252
Model 1 1.00 (Ref.) 0.80 (0.58–1.10) 0.64 (0.46–0.89) 0.52 (0.35–0.79)  < 0.001
Model 2 1.00 (Ref.) 0.82 (0.59–1.13) 0.70 (0.50–0.98) 0.64 (0.42–0.96) 0.015
Model 3 1.00 (Ref.) 0.81 (0.59–1.12) 0.70 (0.50–0.98) 0.64 (0.43–0.97) 0.018

Model 1: age (years), race (Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, other race), marital status (married or cohabitation, widowed or separated, never married), education level (less than 12th grade, high school or equivalent, college graduate or above), family poverty income ratio; Model 2: model 1 + smoking status (never, ever, current), alcohol intake (drinkers/week), leisure activity (MET-min/day), total energy intake (kcal/day), healthy eating index-2015; Model 3: model 2 + lead (μg/dL), cadmium (nmol/L).

AHF advanced hepatic fibrosis, MET metabolic equivalent, NAFLD non-alcohol fatty liver disease.